Proteomics

Dataset Information

0

Exploring Diverse Clinical Presentations in COVID-19 through Circulating Extracellular Vesicle Proteomics Analysis


ABSTRACT: Extracellular vesicles (EVs) released by virus-infected cells are susceptible to incorporate viral peptides. Here, we hypothesized that the molecular characterization of EVs obtained from COVID-19 patients will reveal novel immunogenic viral peptides. Blood from COVID-19 patients with severe (G1), mild/asymptomatic disease (G2) and controls (G3), were collected during active infection (m0) in early 2020 and eight months (m8) post-infection. Clinical data showed increased inflammation markers in G1. Neutralizing antibodies in non-vaccinated G1 individuals increased at m8, indicating sustained exposure to viral antigens. Proteomic profiling of EVs isolated by three different methods, immunocapture (CD9), ganglioside-capture (Siglec-1) and size-exclusion chromatography (SEC), failed in identifying viral peptides. These results were validated by Western blot against Spike-RBD and EV proteomics of hamsters with induced viral infection. Noticeably, G3 individuals showed dramatic changes in EV-associated protein abundance when comparing m0-m8, likely due to vaccination. Human EV cargo identified proteins with prognostic potential in severe disease.

INSTRUMENT(S): Orbitrap Fusion Lumos, Orbitrap Exploris 480

ORGANISM(S): Homo Sapiens (human) Cricetulus Griseus (chinese Hamster) (cricetulus Barabensis Griseus)

TISSUE(S): Blood Plasma

DISEASE(S): Covid-19

SUBMITTER: Joan Josep Bech-Serra  

LAB HEAD: Hernando A.

PROVIDER: PXD041931 | Pride | 2024-09-25

REPOSITORIES: Pride

Similar Datasets

2022-05-25 | E-MTAB-11650 | biostudies-arrayexpress
2010-02-24 | E-GEOD-17400 | biostudies-arrayexpress
2023-09-22 | E-MTAB-13308 | biostudies-arrayexpress
2021-07-01 | PXD024566 | Pride
2021-05-19 | PXD021871 | Pride
2021-09-10 | PXD023614 | Pride
2021-06-28 | PXD025499 | Pride
2023-10-22 | PXD044432 | Pride
2024-02-16 | PXD036798 | Pride
2020-12-03 | PXD022017 | Pride